Medicamen Biotech Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
430.74 Cr.
|
P/BV
|
1.99
|
Book Value (Rs.)
|
159.80
|
52 Week High/Low (Rs.)
|
630/293
|
FV/ML
|
10/1
|
P/E(X)
|
60.60
|
Bookclosure
|
19/09/2025
|
EPS (Rs.)
|
5.24
|
Div Yield (%)
|
0.31
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 5.16 | 7.50 | 11.92 | 12.19 | 9.93 |
Diluted EPS (Rs.) | 5.16 | 7.50 | 11.92 | 12.19 | 9.93 |
Cash EPS (Rs.) | 10.71 | 13.05 | 16.67 | 16.92 | 11.99 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 167.35 | 162.79 | 150.82 | 119.89 | 108.78 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 167.35 | 162.79 | 150.82 | 119.89 | 108.78 |
Revenue From Operations / Share (Rs.) | 127.84 | 141.02 | 111.35 | 94.50 | 92.26 |
PBDIT / Share (Rs.) | 15.81 | 19.32 | 20.82 | 20.68 | 16.35 |
PBIT / Share (Rs.) | 10.25 | 13.74 | 15.78 | 15.96 | 14.29 |
PBT / Share (Rs.) | 7.77 | 10.28 | 13.47 | 14.81 | 13.42 |
Net Profit / Share (Rs.) | 5.16 | 7.47 | 11.64 | 12.19 | 9.93 |
NP After MI And SOA / Share (Rs.) | 5.59 | 8.60 | 11.73 | 12.19 | 9.93 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 12.36 | 13.70 | 18.69 | 21.88 | 17.72 |
PBIT Margin (%) | 8.01 | 9.74 | 14.17 | 16.88 | 15.48 |
PBT Margin (%) | 6.07 | 7.29 | 12.10 | 15.67 | 14.54 |
Net Profit Margin (%) | 4.03 | 5.29 | 10.45 | 12.90 | 10.76 |
NP After MI And SOA Margin (%) | 4.37 | 6.09 | 10.53 | 12.90 | 10.76 |
Return on Networth / Equity (%) | 3.34 | 5.28 | 7.77 | 10.17 | 9.12 |
Return on Capital Employeed (%) | 5.96 | 8.32 | 10.19 | 12.74 | 12.40 |
Return On Assets (%) | 2.39 | 3.71 | 5.32 | 6.60 | 6.25 |
Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.00 | 0.03 | 0.04 |
Total Debt / Equity (X) | 0.15 | 0.14 | 0.12 | 0.16 | 0.13 |
Asset Turnover Ratio (%) | 0.54 | 0.62 | 0.55 | 0.55 | 0.58 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 2.11 | 1.89 | 1.98 | 1.69 | 1.80 |
Quick Ratio (X) | 1.31 | 1.19 | 1.43 | 1.32 | 1.70 |
Inventory Turnover Ratio (X) | 1.49 | 2.00 | 2.27 | 3.46 | 5.94 |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 8.52 | 8.20 | 0.00 |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 5.96 | 5.91 | 0.00 |
Earning Retention Ratio (%) | 0.00 | 0.00 | 91.48 | 91.80 | 0.00 |
Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 94.04 | 94.09 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 6.37 | 5.59 | 9.01 | 18.04 | 18.78 |
Interest Coverage Ratio (Post Tax) (%) | 3.08 | 3.16 | 6.04 | 11.64 | 12.40 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 641.96 | 503.13 | 832.75 | 806.91 | 665.81 |
EV / Net Operating Revenue (X) | 3.95 | 2.81 | 5.91 | 6.99 | 5.91 |
EV / EBITDA (X) | 31.93 | 20.48 | 31.62 | 31.94 | 33.33 |
MarketCap / Net Operating Revenue (X) | 3.77 | 2.72 | 5.89 | 6.81 | 5.79 |
Retention Ratios (%) | 0.00 | 0.00 | 91.47 | 91.79 | 0.00 |
Price / BV (X) | 2.88 | 2.35 | 4.35 | 5.37 | 4.91 |
Price / Net Operating Revenue (X) | 3.77 | 2.72 | 5.89 | 6.81 | 5.79 |
EarningsYield | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |